# SUGAMMADEX
> **ANDA214311** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2025-05-20
## Drug
- **FDA Application Number:** ANDA214311
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUGAMMADEX
- **Generic name:** Sugammadex
- **Active ingredients:** SUGAMMADEX
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SANDOZ INC
- **First approval:** 2025-05-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214311)
---
*AI Analytics · CC0 1.0*